EyebioKorea, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration (NCT06487039) | EyebioKorea, Inc. | 2024-08-01 |
| Safety, Tolerability and Pharmacokinetics of EB-203 Eye Drops in Healthy Volunteers (NCT05538949) | EyebioKorea, Inc. | 2022-06-29 |
Track EyebioKorea, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.